Rubella Diagnostic Testing Market 2027 by Testing Technique, Application and Geography | The Insight Partners

Rubella Diagnostic Testing Market to 2027 - Global Analysis and Forecasts By Testing Technique ( Serological Testing, Latex Agglutination, Enzyme Immunoassay (EIA), Radioimmunoassay (RIA), Fluorescent Immunoassay (FIA), Other Testing Techniques ); Application ( Hospitals, Laboratories, Other Applications ) and Geography

Report Code: TIPRE00006975 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
MARKET INTRODUCTION

Rubella/German measles, also called three-day measles, is a contagious disease caused by a viral infection in children. Rubella causes a red rash and a mild fever in children; however, infection during pregnancy can lead to miscarriage, fetal death, stillbirth, or birth with congenital malformations. Rubella diagnostic testing involves the detection of the rubella virus by techniques like latex slide agglutination test, immunoassays, serological testing, and others.

MARKET DYNAMICS

The rubella diagnostic testing market is anticipated to grow in the forecast, owing to a rising number of rubella cases across the globe, the development of advanced point-of-care diagnostic technologies, and increasing funds for the development of innovative diagnostic techniques. In addition, growing government initiatives to restrict the rubella virus is expected to offer significant growth opportunities in the market during the forecast period.

MARKET SCOPE

The "Rubella Diagnostic Testing Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of rubella diagnostic testing market with detailed market segmentation by testing technique, application and geography. The rubella diagnostic testing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading rubella diagnostic testing market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The rubella diagnostic testing market is segmented on the basis of testing technique and application. Based on testing technique the market is segmented as serological testing, latex agglutination, enzyme immunoassay (EIA), radioimmunoassay (RIA), fluorescent immunoassay (FIA), and other testing techniques. The application segment is classified into hospitals, laboratories, and other applications.

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the rubella diagnostic testing market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The rubella diagnostic testing market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting rubella diagnostic testing market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the rubella diagnostic testing market in these regions.

MARKET PLAYERS


The report covers key developments in the rubella diagnostic testing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Rubella diagnostic testing market are anticipated to have lucrative growth opportunities in the future with the rising demand for rubella diagnostic testing market in the global market. Below mentioned is the list of few companies engaged in the rubella diagnostic testing market.

The report also includes the profiles of key rubella diagnostic testing market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  •  ZEUS Scientific Inc.
  •  Abbott
  •  Beckman Coulter Inc.
  •  Bio Rad Laboratories Inc.
  •  Biokit SA
  •  bioMérieux SA
  •  F. Hoffmann-La Roche Ltd
  •  Ortho Clinical Diagnostics
  •  Siemens Healthcare GmbH
  •  Thermo Fisher Scientific

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Rubella Diagnostic Testing Market - By Testing Technique
1.3.2 Rubella Diagnostic Testing Market - By Application
1.3.3 Rubella Diagnostic Testing Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. RUBELLA DIAGNOSTIC TESTING MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. RUBELLA DIAGNOSTIC TESTING MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. RUBELLA DIAGNOSTIC TESTING MARKET - GLOBAL MARKET ANALYSIS
6.1. RUBELLA DIAGNOSTIC TESTING - GLOBAL MARKET OVERVIEW
6.2. RUBELLA DIAGNOSTIC TESTING - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. RUBELLA DIAGNOSTIC TESTING MARKET - REVENUE AND FORECASTS TO 2027 - TESTING TECHNIQUE
7.1. OVERVIEW
7.2. TESTING TECHNIQUE MARKET FORECASTS AND ANALYSIS
7.3. SEROLOGICAL TESTING
7.3.1. Overview
7.3.2. Serological Testing Market Forecast and Analysis
7.4. LATEX AGGLUTINATION
7.4.1. Overview
7.4.2. Latex Agglutination Market Forecast and Analysis
7.5. ENZYME IMMUNOASSAY (EIA)
7.5.1. Overview
7.5.2. Enzyme Immunoassay (EIA) Market Forecast and Analysis
7.6. RADIOIMMUNOASSAY (RIA)
7.6.1. Overview
7.6.2. Radioimmunoassay (RIA) Market Forecast and Analysis
7.7. FLUORESCENT IMMUNOASSAY (FIA)
7.7.1. Overview
7.7.2. Fluorescent Immunoassay (FIA) Market Forecast and Analysis
7.8. OTHER TESTING TECHNIQUES
7.8.1. Overview
7.8.2. Other Testing Techniques Market Forecast and Analysis
8. RUBELLA DIAGNOSTIC TESTING MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. LABORATORIES
8.4.1. Overview
8.4.2. Laboratories Market Forecast and Analysis
8.5. OTHER APPLICATIONS
8.5.1. Overview
8.5.2. Other Applications Market Forecast and Analysis
9. RUBELLA DIAGNOSTIC TESTING MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Rubella Diagnostic Testing Market Overview
9.1.2 North America Rubella Diagnostic Testing Market Forecasts and Analysis
9.1.3 North America Rubella Diagnostic Testing Market Forecasts and Analysis - By Testing Technique
9.1.4 North America Rubella Diagnostic Testing Market Forecasts and Analysis - By Application
9.1.5 North America Rubella Diagnostic Testing Market Forecasts and Analysis - By Countries
9.1.5.1 United States Rubella Diagnostic Testing Market
9.1.5.1.1 United States Rubella Diagnostic Testing Market by Testing Technique
9.1.5.1.2 United States Rubella Diagnostic Testing Market by Application
9.1.5.2 Canada Rubella Diagnostic Testing Market
9.1.5.2.1 Canada Rubella Diagnostic Testing Market by Testing Technique
9.1.5.2.2 Canada Rubella Diagnostic Testing Market by Application
9.1.5.3 Mexico Rubella Diagnostic Testing Market
9.1.5.3.1 Mexico Rubella Diagnostic Testing Market by Testing Technique
9.1.5.3.2 Mexico Rubella Diagnostic Testing Market by Application
9.2. EUROPE
9.2.1 Europe Rubella Diagnostic Testing Market Overview
9.2.2 Europe Rubella Diagnostic Testing Market Forecasts and Analysis
9.2.3 Europe Rubella Diagnostic Testing Market Forecasts and Analysis - By Testing Technique
9.2.4 Europe Rubella Diagnostic Testing Market Forecasts and Analysis - By Application
9.2.5 Europe Rubella Diagnostic Testing Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Rubella Diagnostic Testing Market
9.2.5.1.1 Germany Rubella Diagnostic Testing Market by Testing Technique
9.2.5.1.2 Germany Rubella Diagnostic Testing Market by Application
9.2.5.2 France Rubella Diagnostic Testing Market
9.2.5.2.1 France Rubella Diagnostic Testing Market by Testing Technique
9.2.5.2.2 France Rubella Diagnostic Testing Market by Application
9.2.5.3 Italy Rubella Diagnostic Testing Market
9.2.5.3.1 Italy Rubella Diagnostic Testing Market by Testing Technique
9.2.5.3.2 Italy Rubella Diagnostic Testing Market by Application
9.2.5.4 Spain Rubella Diagnostic Testing Market
9.2.5.4.1 Spain Rubella Diagnostic Testing Market by Testing Technique
9.2.5.4.2 Spain Rubella Diagnostic Testing Market by Application
9.2.5.5 United Kingdom Rubella Diagnostic Testing Market
9.2.5.5.1 United Kingdom Rubella Diagnostic Testing Market by Testing Technique
9.2.5.5.2 United Kingdom Rubella Diagnostic Testing Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Rubella Diagnostic Testing Market Overview
9.3.2 Asia-Pacific Rubella Diagnostic Testing Market Forecasts and Analysis
9.3.3 Asia-Pacific Rubella Diagnostic Testing Market Forecasts and Analysis - By Testing Technique
9.3.4 Asia-Pacific Rubella Diagnostic Testing Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Rubella Diagnostic Testing Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Rubella Diagnostic Testing Market
9.3.5.1.1 Australia Rubella Diagnostic Testing Market by Testing Technique
9.3.5.1.2 Australia Rubella Diagnostic Testing Market by Application
9.3.5.2 China Rubella Diagnostic Testing Market
9.3.5.2.1 China Rubella Diagnostic Testing Market by Testing Technique
9.3.5.2.2 China Rubella Diagnostic Testing Market by Application
9.3.5.3 India Rubella Diagnostic Testing Market
9.3.5.3.1 India Rubella Diagnostic Testing Market by Testing Technique
9.3.5.3.2 India Rubella Diagnostic Testing Market by Application
9.3.5.4 Japan Rubella Diagnostic Testing Market
9.3.5.4.1 Japan Rubella Diagnostic Testing Market by Testing Technique
9.3.5.4.2 Japan Rubella Diagnostic Testing Market by Application
9.3.5.5 South Korea Rubella Diagnostic Testing Market
9.3.5.5.1 South Korea Rubella Diagnostic Testing Market by Testing Technique
9.3.5.5.2 South Korea Rubella Diagnostic Testing Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Rubella Diagnostic Testing Market Overview
9.4.2 Middle East and Africa Rubella Diagnostic Testing Market Forecasts and Analysis
9.4.3 Middle East and Africa Rubella Diagnostic Testing Market Forecasts and Analysis - By Testing Technique
9.4.4 Middle East and Africa Rubella Diagnostic Testing Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Rubella Diagnostic Testing Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Rubella Diagnostic Testing Market
9.4.5.1.1 South Africa Rubella Diagnostic Testing Market by Testing Technique
9.4.5.1.2 South Africa Rubella Diagnostic Testing Market by Application
9.4.5.2 Saudi Arabia Rubella Diagnostic Testing Market
9.4.5.2.1 Saudi Arabia Rubella Diagnostic Testing Market by Testing Technique
9.4.5.2.2 Saudi Arabia Rubella Diagnostic Testing Market by Application
9.4.5.3 U.A.E Rubella Diagnostic Testing Market
9.4.5.3.1 U.A.E Rubella Diagnostic Testing Market by Testing Technique
9.4.5.3.2 U.A.E Rubella Diagnostic Testing Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South & Central America Rubella Diagnostic Testing Market Overview
9.5.2 South & Central America Rubella Diagnostic Testing Market Forecasts and Analysis
9.5.3 South & Central America Rubella Diagnostic Testing Market Forecasts and Analysis - By Testing Technique
9.5.4 South & Central America Rubella Diagnostic Testing Market Forecasts and Analysis - By Application
9.5.5 South & Central America Rubella Diagnostic Testing Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Rubella Diagnostic Testing Market
9.5.5.1.1 Brazil Rubella Diagnostic Testing Market by Testing Technique
9.5.5.1.2 Brazil Rubella Diagnostic Testing Market by Application
9.5.5.2 Argentina Rubella Diagnostic Testing Market
9.5.5.2.1 Argentina Rubella Diagnostic Testing Market by Testing Technique
9.5.5.2.2 Argentina Rubella Diagnostic Testing Market by Application
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. RUBELLA DIAGNOSTIC TESTING MARKET, KEY COMPANY PROFILES
11.1. ZEUS SCIENTIFIC INC.
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. ABBOTT
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. BECKMAN COULTER INC.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. BIO RAD LABORATORIES INC.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. BIOKIT SA
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. BIOMéRIEUX SA
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. F. HOFFMANN-LA ROCHE LTD
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. ORTHO CLINICAL DIAGNOSTICS
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. SIEMENS HEALTHCARE GMBH
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. THERMO FISHER SCIENTIFIC
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. ZEUS Scientific Inc.
2. Abbott
3. Beckman Coulter Inc.
4. Bio Rad Laboratories Inc.
5. Biokit SA
6. bioMérieux SA
7. F. Hoffmann-La Roche Ltd
8. Ortho Clinical Diagnostics
9. Siemens Healthcare GmbH
10. Thermo Fisher Scientific